Featured interview with Targeted Oncology
In this Targeted Oncology article, ConcertAI Chief Medical Officer of Oncology Shaalan Beg, MD, explores how agentic AI is helping address some of the challenges associated with clinical trial enrollment and patient matching. He discusses how AI can help surface relevant patient and clinical data at the right time, reducing the administrative burden placed on oncology teams and making the trial screening process more efficient.
The article also explores the potential for AI-driven tools to expand access to clinical trials, particularly for patients receiving care in community settings outside of large academic medical centers. By making it easier for care teams to identify appropriate trials and potential participants, these technologies have the potential to help more patients access innovative treatment options while supporting more efficient clinical research.